Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...

The most common adverse reactions included systemic infusion-related reactions and hypersensitivity ... to PEMGARDA and national variant frequencies. VYD2311 is a novel monoclonal antibody (mAb) ...

Their new study, published in Science Translational Medicine, identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed ...

James Harrison earned the nickname “The Man With the Golden Arm” because his blood had a rare antibody that may have helped more than two million babies in Australia. By Amelia Nierenberg ...

formulations for monoclonal antibodies (mAbs), as an alternative to conventional intravenous (IV) infusion, represents a shift in health care delivery. The relative environmental impact of these two ...

Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH)—a rare, aggressive hyperinflammatory condition—who were treated with the first-in-class monoclonal ...

Five regional infusion centers in Texas have run out of a monoclonal antibody that has shown to be effective against the omicron variant of COVID-19, the Texas Department of State Health Services ...

Photos courtesy of Avera Marshall An IV infusion of monoclonal antibodies — lab-grown proteins that can help boost immune response — can help keep people with COVID-19 from developing more ...